article thumbnail

Adaptive Biotechnologies’ new HQ: Co-founders show off 100K square-foot space in Seattle

GeekWire

Adaptive co-founders Harlan (left) and Chad Robins on the plaza at the new Adaptive Biotechnology headquarters. After doubling its workforce during the pandemic, Adaptive Biotechnologies finally has room to grow. The labs are designed modularly — the bench space is mobile and can easily be reconfigured.

article thumbnail

Vote for Startup CEO of the Year: These five leaders are taking their companies to new heights

GeekWire

Clockwise, from top left: SEngine Precision CEO Carla Grandori; Joon Care CEO Emily Pesce; FlavorCloud CEO Rathna Sharad; AltPep CEO Valerie Daggett; and Strella Biotechnology CEO Katherine Sizov. Submit your vote here or below and keep scrolling for descriptions of each finalist for Startup of the Year, presented by T-Mobile.

Company 102
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GeekWire Awards: How these five Workplace of the Year finalists navigate challenging times

GeekWire

Workplace of the Year finalists, clockwise from top left: Adaptive Biotechnologies co-founders Harlan and Chad Robins; the Helion team; Impinj offices in Seattle; Treasury4 team; Blink CEO Karen Clark Cole. This year’s finalists are Adaptive Biotechnologies, Blink, Helion, Impinj and Treasury4. Blink Blink CEO Karen Clark Cole.

article thumbnail

Vancouver, Wash. biotech company Absci files to go public

GeekWire

based company developing technologies to accelerate the process of drug discovery, announced today that it plans to go public via an IPO. Absci aims to circumvent current processes for developing protein-based drugs, which often require manufacture in mammalian cells, a cumbersome and difficult method. Absci Photo).

Company 133
article thumbnail

Protein design to precision health: Vote for Health Innovation of the Year at the GeekWire Awards

GeekWire

The category highlights pioneering health, life science, biotechnology or medical breakthroughs that hold great promise for bettering our lives or improving the healthcare system. Good Therapeutics Graphic) Developing therapeutics that are active only where they are needed in the body has the potential to reduce toxic side effects.

article thumbnail

Eliem Therapeutics files for IPO as another Seattle-area biotech firm set to go public

GeekWire

Eliem has two lead drug candidates in development: ETX-810 for chronic pain conditions and ETX-155 for mood disorders and epilepsy. In June, Seattle-based Nautilus Biotechnology, led by Isilon Systems co-founder Sujal Patel, went public via a SPAC merger. It aims to raise up to $80 million with the IPO. Eliem’s tech.

article thumbnail

Testing a new COVID-19 test: How T-cells beat antibodies in helping to detect past infections

GeekWire

On a cold, clear weekday morning last month, my quest to figure out whether I had COVID-19 in the early days of the pandemic took me to my back porch, where a mobile phlebotomist drew blood from my arm. Adaptive Biotechnologies’ new test, called T-Detect COVID , was developed in partnership with Microsoft.